Results 141 to 150 of about 15,899 (181)

Carbapenemase-producing , Algeria

open access: yes, 2010
Drissi, M.   +4 more
openaire   +1 more source

Update on the epidemiology of carbapenemases in Latin America and the Caribbean

open access: yesExpert Review of Anti-Infective Therapy, 2021
Disponible en: https://www.tandfonline.com/doi/abs/10.1080/14787210.2020.1813023Abstract Introduction: Carbapenemases are β-lactamases able to hydrolyze a wide range of β-lactam antibiotics, including carbapenems.
Tobias Manuel Appel   +2 more
exaly   +4 more sources

Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe

open access: yesClinical Microbiology and Infection, 2012
Plasmid-acquired carbapenemases in Enterobacteriaceae, which were first discovered in Europe in the 1990s, are now increasingly being identified at an alarming rate.
Rafael Canton   +2 more
exaly   +2 more sources

Structural Basis for Carbapenem-Hydrolyzing Mechanisms of Carbapenemases Conferring Antibiotic Resistance

open access: yesInternational Journal of Molecular Sciences, 2015
Carbapenems (imipenem, meropenem, biapenem, ertapenem, and doripenem) are β-lactam antimicrobial agents. Because carbapenems have the broadest spectra among all β-lactams and are primarily used to treat infections by multi-resistant Gram-negative ...
Chang-Ro Lee   +2 more
exaly   +2 more sources

Current methods for the identification of carbapenemases

Journal of Chemotherapy, 2016
Detection of carbapenemases in clinical microbiology labs is a challenging issue. Comparison of the results of susceptibility testing with the breakpoint values of carbapenems is the first step in the screening of carbapenemase producers. To date, screening of carbapenemase-producing (CP) bacteria has been mostly performed by a selective medium ...
Abed Zahedi Bialvaei   +2 more
exaly   +3 more sources

Emerging carbapenemases: a global perspective

International Journal of Antimicrobial Agents, 2010
The celestial rise in antibiotic resistance among Gram-negative bacteria has challenged both the scientific and pharmaceutical sectors. The hallmark of this general increase is the unbridled dissemination of carbapenem resistance genes, namely KPC, OXA and metallo-β-lactamase variants.
Timothy R Walsh
exaly   +3 more sources

Home - About - Disclaimer - Privacy